<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Seventeen cytogenetic laboratories in eight European countries contributed karyotypic, hematological, clinical and follow-up data from 550 patients with an acquired abnormality of 11q23 </plain></SENT>
<SENT sid="1" pm="."><plain>The patients had <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (254), <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (250), unspecified, undifferentiated, <z:hpo ids='HP_0005531'>biphenotypic acute leukemia</z:hpo> or <z:hpo ids='HP_0005547'>myeloproliferative disorder</z:hpo> (18 cases together), or <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) (28) </plain></SENT>
<SENT sid="2" pm="."><plain>The patients were classified by cytogenetic subgroup as t(4;11) (183 cases), t(6;11) (30) cases), t(9;11) (125 cases), t(10;11) (20 cases), t(11;19) (53 cases), 'other' abnormalities of 11q23 (82 cases) and del(11)(q23) (57 cases) </plain></SENT>
<SENT sid="3" pm="."><plain>Manuscripts were prepared on each cytogenetic subgroup, on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, on secondary <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> (40 cases) and on 11q23-translocation derivatives </plain></SENT>
<SENT sid="4" pm="."><plain>For each subgroup the following aspects were investigated: associated clinical features, additional karyotypic change, distribution between hematological subtypes and between different age groups, prognosis at different age groups, and the impact of bone marrow transplantation on survival </plain></SENT>
<SENT sid="5" pm="."><plain>The Workshop confirmed some previous findings from smaller studies, challenged others, identified new chromosomal partners and threw new light on less well documented aspects of 11q23 <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The large number of cases investigated in a coordinated manner gives authoritative support to the findings </plain></SENT>
<SENT sid="7" pm="."><plain>The Workshop thus demonstrates the value of collaborative European studies in the cytogenetics of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
</text></document>